Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  hydromorphone hydrochloride
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-11 of 11 for your search:
Start Over
An Efficacy and Safety Study of Hydromorphone Oral Osmotic System (OROS) in Korean Participants With Cancer Pain
Phase: Phase IV
Type: Supportive care
Status: Completed
Age: 20 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CR014806, HYD-KOR-4002, NCT00766831
An Efficacy and Safety Study of Hydromorphone Hydrochloride (HCl) Oral Osmotic System (OROS) in the Reduction of Breakthrough Pain Medication Frequency in Participants With Cancer
Phase: Phase IV
Type: Supportive care
Status: Completed
Age: 20 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CR015694, 42801PAI4006, NCT01006356
Clinical Usefulness and Quality of Life of OROS Hydromorphone in Patients Who Have Not Been Treated With a Strong Opioid
Phase: Phase IV
Type: Supportive care
Status: Completed
Age: 20 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CR100741, 42801PAI4013, HYD-KOR-5011, NCT01532895
Study to Evaluate Effectiveness and Tolerability of OROS Hydromorphone for Cancer Pain Treatment in Korean Patients
Phase: Phase IV
Type: Supportive care
Status: Completed
Age: 20 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CR100659, HYD-KOR-4003, 42801PAI4012, NCT01621100
Epidural Hydromorphone Compared With Hydromorphone Infusion in Treating Patients With Prostate Cancer Undergoing Radical Prostatectomy
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18-70
Sponsor: Other
Protocol IDs: CDR0000065866, RPCI-DS-95-35, NCI-G97-1352, NCT00003115
Evaluate the Use of Paravertebral Block in Reconstructive Breast Surgery
Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 2006-0961, NCI-2012-01557, NCT00542542
An Efficacy and Safety Study of Oral Osmotic Therapeutic System (OROS) Hydromorphone Hydrochloride (HCl) in Participants With Cancer Related Pain
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 to 70
Sponsor: Pharmaceutical / Industry
Protocol IDs: CR017437, 42801PAI3009, NCT01205126
Assessment of Efficacy and Safety in Relieving Opioid-induced Constipation in Patients With Cancer-related Pain
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: D3820C00006, 2011-001985-16, NCT01384292
Phase II Randomized, Double-blind Comparison of Flurbiprofen vs Hydromorphone vs Placebo for Analgesic Effects in Patients with Metastatic Cancer
Phase: Phase II
Type: Supportive care
Status: Completed
Age: 16 and over
Sponsor:
Protocol IDs: NCI-81-C-203, NCI-MB-168
Phase II Clinical Analgesic Assay of Intramuscular Heroin and Hydromorphone (Summary Last Modified 11/87)
Phase: Phase II
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MSKCC-8582, NCI-T85-0066D, T85-0066
Epidural Analgesia or Patient-Controlled Analgesia in Treating Patients Who Have Undergone Surgery for Gynecologic Cancer
Phase: No phase specified
Type: Supportive care
Status: Completed
Age: Not specified
Sponsor: Other
Protocol IDs: CDR0000459963, UCSF-03423, UCSF-H10588-24197-02, NCT00295945
Start Over